Literature DB >> 24636271

Two tracheal BALT lymphoma patients successfully treated with chemotherapy including rituximab.

Yoshihisa Hiraishi1, Motoyasu Iikura2, Yoshihito Kogure3, Junko Hirashima2, Shinyu Izumi2, Haruhito Sugiyama2.   

Abstract

Bronchus-associated lymphoid tissue (BALT) lymphoma of the trachea, an important differential diagnosis for tracheal tumors, is a rare disease with characteristic bronchoscopic findings. In this study, we reviewed 2 cases of patients who were symptomatic at the time of diagnosis, with tumors in the trachea and left main bronchus, putting them at high risk for asphyxia. Chemotherapies including rituximab were administered, and complete remission was confirmed in both cases. Because tracheal tumors often have a pernicious course, it might be beneficial to initiate a chemotherapeutic treatment regimen instead of adopting the "wait-and-see" approach in patients with symptomatic tracheal BALT lymphoma.
© 2013 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BALT; Bronchoscopy; Chemotherapy; Lymphoma; Rituximab

Mesh:

Substances:

Year:  2013        PMID: 24636271     DOI: 10.1016/j.resinv.2013.07.006

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  2 in total

1.  Endobronchial Mucosa-associated Lymphoid Tissue Lymphoma: A Report of Two Cases and a Review of the Literature.

Authors:  Takeshi Kawaguchi; Daisuke Himeji; Noriaki Kawano; Yoshiya Shimao; Kousuke Marutsuka
Journal:  Intern Med       Date:  2018-03-09       Impact factor: 1.271

2.  Mucosa-associated lymphoid tissue lymphoma of the trachea associated with idiopathic pulmonary fibrosis: A case report and literature review.

Authors:  June Hong Ahn; Jin Hong Chung; Kyeong-Cheol Shin; Eun Young Choi; Hyun Jung Jin; Joon Hyuk Choi; Kwan Ho Lee
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.